OC
MGNX icon

Oppenheimer & Co’s MacroGenics MGNX Stock Holding History

Oppenheimer & Co’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-9,857
Closed -$211K – 1331
2015
Q3 		$211K Buy
9,857
+1,682
+21% +$52.8K 0.01% 1146
2015
Q2 		$311K Sell
8,175
-2,688
-25% -$88.3K 0.01% 1078
2015
Q1 		$341K Buy
10,863
+3,363
+45% +$114K 0.01% 1053
2014
Q4 		$263K Sell
7,500
-6,500
-46% -$162K 0.01% 1084
2014
Q3 		$293K Buy
+14,000
New +$290K 0.01% 1076

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Oppenheimer & Co's MGNX Position: Q4 2015 in Review

Oppenheimer & Co sold out of MacroGenics (MGNX) in Q4 2015, closing a stake of 9,857 shares — an estimated $211K sold.

Oppenheimer & Co first reported a position in MGNX in Q3 2014 and held it in 5 quarters. The position peaked at $341K in Q1 2015. 128 funds tracked by Wall St. Rank hold MGNX as of Q4 2015.

  • Oppenheimer & Co reported no remaining MacroGenics position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 9,857 MacroGenics shares in Q4 2015, an estimated $211K.
  • Oppenheimer & Co first reported a position in MacroGenics in Q3 2014 and held it in 5 quarters.
  • Oppenheimer & Co's MacroGenics position peaked at $341K in Q1 2015.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.